BMS-570520
Modify Date: 2025-08-25 12:01:50
BMS-570520 structure
|
Common Name | BMS-570520 | ||
|---|---|---|---|---|
| CAS Number | 388101-58-4 | Molecular Weight | 529.675 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C27H36FN5O3S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of BMS-570520BMS-570520 is a potent, selective CCR3 antagonist with IC50 of 1.9 nM, inhibits eotaxin-induced chemotaxis with IC50 of 0.068 nM.BMS-570520 displays reduced inhibition on CYP2D6 (IC50=1300 nM) compared with DPC168 (IC50=30 nM), also possesses >100-fold selectivity over 5-HT2a, DAT and NET.BMS-570520 showed good activity in murine models of CCR3 antagonism and greater in vitro potency and in vivo in the mouse intranasal eotaxin challenge mode. |
| Name | BMS-570520 |
|---|
| Description | BMS-570520 is a potent, selective CCR3 antagonist with IC50 of 1.9 nM, inhibits eotaxin-induced chemotaxis with IC50 of 0.068 nM.BMS-570520 displays reduced inhibition on CYP2D6 (IC50=1300 nM) compared with DPC168 (IC50=30 nM), also possesses >100-fold selectivity over 5-HT2a, DAT and NET.BMS-570520 showed good activity in murine models of CCR3 antagonism and greater in vitro potency and in vivo in the mouse intranasal eotaxin challenge mode. |
|---|---|
| References | 1. James R Pruitt, et al. Bioorg Med Chem Lett. 2007 Jun 1;17(11):2992-7. |
| Molecular Formula | C27H36FN5O3S |
|---|---|
| Molecular Weight | 529.675 |